Drug Profile
Research programme: phosphodiesterase IVB inhibitors - Plexxikon
Alternative Names: PDE4B inhibitors research programme - Plexxikon; Phosphodiesterase IVB inhibitors research programme - Plexxikon; PLX 369; Research programme: PDE4B inhibitors - PlexxikonLatest Information Update: 07 Jul 2022
Price :
$50
*
At a glance
- Originator Plexxikon
- Class
- Mechanism of Action Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease; Inflammation
Most Recent Events
- 06 Jul 2022 Discontinued - Preclinical for Chronic obstructive pulmonary disease in USA (PO)
- 06 Jul 2022 Discontinued - Preclinical for Inflammation in USA (PO)
- 04 Sep 2007 Lead development is ongoing